位置:成果数据库 > 期刊 > 期刊详情页
HDAC1过表达诱导胶质瘤细胞产生耐药性
  • ISSN号:1007-385X
  • 期刊名称:《中国肿瘤生物治疗杂志》
  • 分类:R739.41[医药卫生—肿瘤;医药卫生—临床医学] R730.54[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:天津医科大学基础医学院药理学教研室,天津300070
  • 相关基金:国家自然科学基金青年科学基金资助项目(No.30701030);天津市应用基础及前沿技术研究计划资助(No.11JCYBJ14900).
中文摘要:

目的:构建组蛋白去乙酰化酶(histone deacetylase 1,HDACl)过表达胶质瘤U87细胞系,探讨HDACl过表达对胶质瘤细胞化疗药耐药性的影响。方法:分别用HDACl重组过表达慢病毒载体pCDH-CMV-MCS-HDACl-EFl-Puro和阴性空载体病毒pCDH-CMV-MCS-EFl-Puro转染U87MG细胞,通过嘌呤梯度浓度筛选出IqDACl稳定过表达细胞系U87MG-HDACl和空载体对照细胞系U87MG-Control,经Western Blotting鉴定,用不同浓度替尼泊苷(VM-26)和顺铂(cisplatin,DDP)对两种细胞进行处理,MTY法检测存活率,Hoechst/PI双染法检测细胞凋亡,WesternBlotting检测Bcl-2、Bax及Caspase-3蛋白表达。结果:成功构建U87MG-HDAC1稳定过表达细胞系。与U87MG-Control组相比,U87MG-HDAC1组中U87MG-HDACl蛋白的表达显著升高[(1.148±0.024)vs(0.580±0.003),P〈0.01];药物处理后,U87MG-HDAC1细胞存活率显著升高[0.1μg/ml VM-26:(95.57±0.45)%vs(68.8±1.49)%,P〈0.01l,[0.08μg/ml DDP:(99.20±7.4)%似(72.48±2.03)%,P〈0.01];凋亡细胞个数比例明显下降(均P〈0.05),Caspase-3蛋白表达量显著降低(P〈0.01),Bcl-2/Bax蛋白表达量比值明显升高(P〈0.01)。结论:胶质瘤U87MG细胞中HDAC1过表达明显增强细胞对化疗药耐药性与Caspase-3和Bcl-2/Bax表达有关。

英文摘要:

Objective:To explore the effect of histone deacetylase 1 (HDAC1) over-expression on drug resistance of glioma cells. Methods: U87MG ceils were infected with a recombinant lentiviral vector pCDH-CMV-MCS-HDAC1-EF1- Puro/over-expressing HDAC1 and a control lentiviral pCDH-CMV-MCS-EFI-Puro, respectively. Cell line U87MG- HDAC1 which stably over expressing HDAC1, and control cell line U87MG-Control were selected with purine gradient concentration and identified by Western blotting. After processed with VM-26 and DDP at different concentrations assessed by MTT of the cells was evaluated by Hoechst/PI double staining assay, and the expressions of Bcl-2,Bax and Caspase-3 were examined by Western blotting. Results: Cell line U87MG-HDAC1 that stably over expressing HDAC1 was successfu- ly constructed. Compared with U87GM-Control group, the expression of U87MG-HDAC1 protein was significantly in- creased in U87MG-HDAC1 group ( [ 1. 148± 0.024 ] vs [ 0.580 ± 0. 003 ], P 〈 0.01 ). After drug treatment the survival rate of U87MG-HDAC1 cell was remarkably higher (0.1 μg/ml VM-26 : [ 95.57 ± 0.45 ] % vs [ 68.8 ± 1.49 ] %, P 〈 0. 01 ) ; (0.08 μg/ml DDP: [ 99.20± 7.4 ] % vs [ 72.48 ± 2.03 ] %, P 〈 0.01 ) ; Number of apoptotic cells decreased (P 〈 0.05) ; the expression of Caspase-3 protein decreased significantly (P 〈 0.01 ) and the expression ratio of Bcl-2/ Bax proteins was significantly enhanced (P 〈 0.01 ). Conclusion: The over-expression of HDAC1 in glima cell U87MG remarkably enhance of resistance of the ceils to chemotherapeutic drugs, which was mav associated with the exnressions of Caspase-3 and Bcl-2/Bax.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国肿瘤生物治疗杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科学技术协会
  • 主办单位:中国免疫学会 中国抗癌协会
  • 主编:曹雪涛
  • 地址:上海市杨浦区翔殷路800号
  • 邮编:200433
  • 邮箱:cjcb@biother.com
  • 电话:021-55620605-22 81871002-22
  • 国际标准刊号:ISSN:1007-385X
  • 国内统一刊号:ISSN:31-1725/R
  • 邮发代号:4-576
  • 获奖情况:
  • 《中国学术期刊(光盘版)检索与评价数据规范》第...
  • 国内外数据库收录:
  • 俄罗斯文摘杂志,美国化学文摘(网络版),英国农业与生物科学研究中心文摘,波兰哥白尼索引,荷兰文摘与引文数据库,荷兰医学文摘,美国剑桥科学文摘,中国中国科技核心期刊,中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),瑞典开放获取期刊指南
  • 被引量:6458